Status:
COMPLETED
Association Between Body Mass Index and HFNC Therapy Success
Lead Sponsor:
Clínica del country
Conditions:
Covid19
Obesity
Eligibility:
All Genders
18+ years
Brief Summary
Patients over 18 years of age who are admitted to the Intermediate Care Unit of the Clinica del Country and the Clinica la Colina, with symptoms suggestive of severe pneumonia secondary to COVID-19 in...
Detailed Description
All adult patients over 18 years of age admitted to the intermediate care service of the participating center with suspected SARS-CoV-2 pneumonia will be considered as potential candidates for the stu...
Eligibility Criteria
Inclusion
- Patients over 18 years of age.
- Diagnosis of severe pneumonia secondary to COVID-19 infection and acute respiratory distress syndrome, defined by upper and lower respiratory symptoms plus positive C-reactive protein test for COVID-19.
- Patient admission to the Clinical del Country and Clinica de la Colina intermediate care units.
- Oxygen therapy by high-flow system (high-flow cannula) requirement.
- Anthropometric data availability upon admission to our facilities.
Exclusion
- Patients with a survival expectancy of less than 12 months according to the Charlson scale categorization or patients with oncological pathology.
- Patients under 18 years of age.
- Pregnant women.
- Patients with cardiogenic pulmonary edema.
- History of chronic liver disease or cirrhosis Child - Pugh C.
- Patients with contraindications to high-flow cannula therapy initiation.
- Patients with respiratory, hemodynamic and neurological indications that contraindicate HFNC initiation.
Key Trial Info
Start Date :
March 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
303 Patients enrolled
Trial Details
Trial ID
NCT04799132
Start Date
March 11 2020
End Date
March 1 2021
Last Update
March 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clínica del Country.
Bogotá, Colombia